Remi Edelstahl Tubulars Limited reported a net profit of ₹274.25 lakh for the financial year ended March 31, 2026 (FY26), an increase from ₹267.19 lakh in FY25. The company’s revenue from operations rose to ₹14,291.88 lakh from ₹13,907.50 lakh in the prior year, while EBITDA improved to ₹911.22 lakh from ₹839.93 lakh. Production volume increased to 3,320.86 tons compared to 3,045.14 tons in FY25. The Board of Directors did not declare a dividend for the year.

The primary focus of the upcoming 55th Annual General Meeting (AGM), scheduled for August 31, 2026, is the approval of two preferential issues aggregating ₹22.15 crore. These funds are designated for capital expenditure at existing manufacturing facilities by March 2027. The first issuance involves convertible warrants worth ₹7,15,27,950 to WSG Co., Ltd., a South Korean entity, to facilitate technology transfer for manufacturing Ultra High Purity (UHP) stainless steel tubes. The second issuance involves equity shares worth ₹15 crore to promoter group entities and non-promoters.

Preferential Issue Details

The company proposes to raise capital through the following instruments:

The convertible warrants will be issued at ₹180 per warrant, with each warrant convertible into one equity share of face value ₹10 within 18 months. The equity shares will also be issued at ₹180 per share. The issue price was determined based on a valuation report dated July 31, 2026, by Independent Registered Valuer Ms. Payal Gada, as the shares are infrequently traded.

Board and Director Changes

The AGM will also address changes in the Board of Directors. Shri Ritvik Saraf is proposed for appointment as a Non-Executive Non-Independent Director, replacing Shri Vishwambhar C. Saraf who resigned due to age. Shri Ankur Sanjay Mehta is proposed as an Independent Director for a five-year term, replacing Shri Mahabir Prasad Sharma who resigned due to health issues. Shri Rajendra C. Saraf retires by rotation and seeks re-appointment.

Financial Health and Operational Metrics

The company’s total assets stood at ₹13,761.76 lakh as of March 31, 2026, up from ₹7,670.70 lakh in FY25. Borrowings increased significantly, with current borrowings rising to ₹3,468.25 lakh from ₹596.19 lakh. This increase in debt led to a decline in the current ratio from 2.80 to 1.73 and an increase in the debt-equity ratio from 0.33 to 0.76. Finance costs rose to ₹202.51 lakh from ₹135.86 lakh in the previous year.

What the Numbers Show

The financial data reveals a strategic shift towards leverage-funded expansion. While operational profitability (EBITDA) grew moderately by approximately 8.5%, the surge in finance costs—driven by increased short-term borrowings—compressed the net profit growth to just over 2%. The significant rise in trade receivables to ₹2,351.12 lakh from ₹1,653.52 lakh suggests expanding credit sales or slower collections, which may impact working capital efficiency. The company is relying on external funding to execute its high-value UHP tube project, indicating that internal cash flows are currently insufficient to support this specific capital-intensive growth initiative.

Remi Edelstahl Tubulars reported a net profit of ₹45.14 lakh for the quarter ended June 30, 2026, marking a 114% year-on-year increase from ₹21.07 lakh in Q1FY26. Revenue from operations rose to ₹3,537.17 lakh from ₹2,734.74 lakh in the prior period, driven by higher order inflows in its stainless steel tube business. The Board of Directors also approved a ₹22.20 crore preferential allotment to finance a ₹27.50 crore capital expenditure aimed at expanding capacity for Ultra High Purity (UHP) tubes, signaling strategic growth despite margin pressures from rising energy costs.

The financial results were reviewed by Sundarlal, Desai & Kanodia, Chartered Accountants, under Regulation 33 of the SEBI Listing Regulations. The Board also reappointed Kejriwal & Associates as Cost Auditors and SIGMAC & Co., Chartered Accountants, as Internal Auditors for FY2026-27. These appointments comply with Sections 148 and 138 of the Companies Act, 2013, respectively.

Preferential Allotment Details

The Board approved the issuance of equity shares and convertible warrants to raise ₹22.20 crore. The allotment is structured across promoter and non-promoter categories at an issue price of ₹180 per share or warrant:

WSG Co., Ltd. warrants are convertible into equity shares within 18 months. Twenty-five percent of the consideration is payable at application, with the balance due upon conversion.

Board Changes and Capital Expenditure

Vishwambhar C. Saraf resigned as Non-Executive Non-Independent Director effective August 1, 2026, citing advanced age. He has been appointed Chairman Emeritus. Ritvik Saraf was appointed as Promoter, Non-Executive, Non-Independent Director to replace him. Rajendra C. Saraf was designated as Non-Executive Chairman effective August 1, 2026.

The company approved ₹27.50 crore in capital expenditure to add 500 MTPA to its existing 900 MTPA UHP tube capacity within 12 months. UHP tubes serve specialized sectors including pharma, food & dairy, semiconductor, and solar industries. The current order book stands at approximately ₹114 crore, including export orders from Middle East clients.

What the Numbers Show

While revenue grew significantly, profitability remained thin with a net profit margin of approximately 1.3%. Management attributed the pressure on margins to increased energy costs due to geopolitical disturbances in the Middle East. The strategic focus on high-margin UHP tubes, currently in trial production, aims to improve this dynamic as trial orders are executed in the coming quarter.